Your Partner In Psychiatry Research

Accelerate your psychiatry clinical trials with Elligo Health Research®. Our extensive network of specialized Healthcare-First psychiatry research sites is dedicated to advancing psychiatric care through cutting-edge clinical studies. With an impressive 107% enrollment rate in ADHD trials and a rapid 20-day average start-up time, we are reshaping the landscape of psychiatry clinical research.

Elligo’s approach to psychiatry clinical trials is as multifaceted as the human mind itself. Our sites are equipped to conduct a wide array of mental health studies, from mood disorders and anxiety to schizophrenia and bipolar disorder. This breadth of focus ensures your research benefits from our depth of experience and specialized knowledge. Our commitment to integrating clinical practice with research means we can reach a broader patient population, thereby enhancing enrollment and retention rates.